{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:29Z","timestamp":1791233129823,"version":"4.1.0"},"reference-count":77,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/13543776.2026.2621091","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:10:28Z","timestamp":1769047828000},"page":"203-224","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: updated patent review (2019\u20132023)"],"prefix":"10.1080","volume":"36","author":[{"given":"Rafia","family":"Ashfaq","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of Okara","place":["Okara, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8654-8127","authenticated-orcid":false,"given":"Hidayat","family":"Hussain","sequence":"additional","affiliation":[{"name":"Heze Branch of Qilu University of Technology (Shandong Academy of Sciences)","place":["Heze, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2016.12.004"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5RA01754H"},{"key":"e_1_3_5_5_1","unstructured":"International Diabetes Federation. IDF diabetes atlas-7th edition. DiabetesAtlas 2021. Available from: http:\/\/www.diabetesatlas.org\/"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.151"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573399819666230413094200"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2014.947268"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1728"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.20142"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S009"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2323078"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01038-3"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105626"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2023.2168643"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.012"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2022.100131"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2019.1655542"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173805"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137027"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199020"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm990260v"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1528"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.05.060"},{"key":"e_1_3_5_25_1","unstructured":"Zhang T Zheng S Qian J et al. Preparation of allyl containing chalcone derivative as PTP1B inhibitor for treating type-II diabetes. CN109503351. 2019."},{"key":"e_1_3_5_26_1","unstructured":"Sun L Piao H Xu L. Application of chalcones containing carboxymethyl rhodamine structure. CN109528716. 2019."},{"key":"e_1_3_5_27_1","unstructured":"Tian J Li B Si X. Polyisopentenyl flavonoid compound in mulberry leave its extraction and separation method and application in preparation of hypoglycemic drug. CN111333603. 2020."},{"key":"e_1_3_5_28_1","unstructured":"Geng C Chen J He X et al. Isolation of novel diaryl heptyl flavones from Alpinia katsumadai Hayata and application for lowering blood glucose. CN113582981. 2021."},{"key":"e_1_3_5_29_1","unstructured":"Hou A Lei C Yu M. Extraction and purification of isopentenyl flavonol derivative as inhibitor of protein tyrosine phosphatase 1B from Broussonetia papyrifera. CN110872267. 2020."},{"key":"e_1_3_5_30_1","unstructured":"Hou A Lei C Yu M et al. Extraction of dipyranone derivatives from Broussonetia kaempferi Sieb as protein tyrosine phosphatase 1B inhibitor. CN110872306. 2020."},{"key":"e_1_3_5_31_1","unstructured":"Lei C Hou A Yu M et al. Application of isopentenyl flavonoid compound in preparing antidiabetic medicament. CN110898051. 2020."},{"key":"e_1_3_5_32_1","unstructured":"Kim DU Lim HJ Song GS et al. Caffeine and theaflavanoside IV having protein tyrosine phosphatase 1B inhibitory activity and composition for preventing alleviating or treating diabetes mellitus using caffeine and the aflavanoside IV. KR2421305. 2022."},{"key":"e_1_3_5_33_1","unstructured":"Qi S Liang X. Preparation of the xanthen dione compounds and their application. CN110498805. 2019."},{"key":"e_1_3_5_34_1","unstructured":"Qi S. Preparation of anthraquinone compound as enzyme inhibitors. CN109748838. 2019."},{"key":"e_1_3_5_35_1","unstructured":"Zhao F Ma L Wang C et al. A new coumarin compound as tumor agents and antidiabetic agents from Knoxia valerianoides. CN113072526. 2021."},{"key":"e_1_3_5_36_1","unstructured":"Liu C Chen L Li H et al. Separation of xanthone compound for the treatment of diabetes. CN115403590. 2022."},{"key":"e_1_3_5_37_1","unstructured":"Geng C He X Chen J et al. Flavanol-fatty alcohol hybrid its pharmaceutical composition preparation method and application in preparation of hypoglycemic drug or health food. CN111978330. 2020."},{"key":"e_1_3_5_38_1","unstructured":"Zhang D Ye F Li C et al. Extraction and purification of oligolignans from magnolia officinalis as diabetes and hyperlipidemia drugs. CN112457284. 2021."},{"key":"e_1_3_5_39_1","unstructured":"Hu J Xiong J Jiang W et al. Application of triterpene and dimer compounds thereof in preparing drug for treating protein-tyrosine-phosphatase 1B (PTP1B) mediated disease. CN113425730. 2021."},{"key":"e_1_3_5_40_1","unstructured":"Tan Q Zhang S Lai C. Compounds with anti-diabetic activity in plumeria rubra and its preparation method. CN111635450. 2020."},{"key":"e_1_3_5_41_1","unstructured":"Chen J Yang X Li T et al. Epoxy-dammarane-3beta 12beta 25-triol derivative and pharmaceutical composition thereof. CN113730419. 2021."},{"key":"e_1_3_5_42_1","unstructured":"Fang Y Li H Yang Z et al. Proteolysis targeting chimera (PROTAC) compound for targeted degradation of protein tyrosine phosphatase 1B (PTP1B) its preparation method and application in treating and\/or preventing PTP1B protein-related disease. CN115677815. 2023."},{"key":"e_1_3_5_43_1","unstructured":"Guo R Li N Li X et al. Preparation of isosteviol derivatives as PTP1B inhibitors. CN116375582. 2023."},{"key":"e_1_3_5_44_1","unstructured":"Li J Abdubakiev S Zhao H et al. Piperlongumine alkaloid for treating hypoglycemia. CN109350614. 2019."},{"key":"e_1_3_5_45_1","unstructured":"Xiao L. Preparation of (vinylsulfonyl)agrocybenine alkaloid derivatives and its application as PTP1B protein inhibitor drug. CN115872992. 2023."},{"key":"e_1_3_5_46_1","unstructured":"Shoji Y Takeda S Shirahase H. Preparation of tetrahydroisoquinoline compound as PTP-1B inhibitor. WO2020013116. 2020."},{"key":"e_1_3_5_47_1","unstructured":"Meng G Ge W Zhang X et al. Preparation of 5-benzylidene-2-[(2-oxoindolin-3-ylidene)hydrazono]-3-phenyl-thiazolidin-4-ones as PTP1B inhibitors. CN114634500. 2022."},{"key":"e_1_3_5_48_1","unstructured":"Meng G Dou J Ren C et al. Preparation of indolinone thiazolidinone derivatives as PTP1B inhibitors. CN114634501. 2022."},{"key":"e_1_3_5_49_1","unstructured":"Meng G Ge W Zhang X et al. Alkaloid-containing 1H-indole-3-substituted-1 3-thiazolidin-4-one derivative and preparation method and application. CN114634503. 2022."},{"key":"e_1_3_5_50_1","unstructured":"Meng G Dou J Ren C et al. Preparation of indolinone-azo chain containing thiazolidinone compounds and application thereof. CN114634504. 2022."},{"key":"e_1_3_5_51_1","unstructured":"Meng G Tong J Cheng Y et al. Preparation of substituted indolinone-linked-substituted-1 3- thiazolidinone derivatives as PTPB1 inhibitors. CN114634505. 2022."},{"key":"e_1_3_5_52_1","unstructured":"Meng G Tong J Cheng Y et al. Preparation of substituted 1H-indol-2-one-linked-3 5-substituted aryl-1 3-thiazolidinone derivatives. CN114634506. 2022."},{"key":"e_1_3_5_53_1","unstructured":"Sun L Piao H Liu H. PTP1B inhibitor containing indolepropionic acid rhodanine structure and preparation and application thereof. CN110078724. 2019."},{"key":"e_1_3_5_54_1","unstructured":"Zhang K Zheng Y Xu X et al. Preparation of triazole-based chromonethiazoledione derivatives as antidiabetic agent. CN116693520. 2023."},{"key":"e_1_3_5_55_1","unstructured":"Zhang K Zheng Y Xu X. Preparation of thiazolidinedione ethyl ester compound containing chromone structure as PTP1B enzyme inhibitors for treatment and\/or prevention of diabetes. CN116693521. 2023."},{"key":"e_1_3_5_56_1","unstructured":"Sun L Piao H Xu L. 1 3-diarylpyrazole PTP1B inhibitor containing carboxyalkyl rhodamine structure and preparation and application thereof. CN109776520. 2019."},{"key":"e_1_3_5_57_1","unstructured":"Geng C Chen J He X et al. Diarylheptane dimer and pharmaceutical composition and preparation and application in preparing hypoglycemic drugs health food LP-1\u00a0secretagogue GPa inhibitor PTP1B inhibitor \u03b1-glucosidase inhibitor and PTP1B inhibitor thereof. CN113929698. 2022."},{"key":"e_1_3_5_58_1","unstructured":"Guo Y Li J Gong J et al. Application of xishacorene a in manufacture of medicament for treatment of diabetes or obesity. CN109125301. 2019."},{"key":"e_1_3_5_59_1","unstructured":"Liu H. Bromophenol compound containing isoprene and preparation method and application thereof. CN110066218. 2019."},{"key":"e_1_3_5_60_1","unstructured":"Hou A Lei C Yu M et al. Application of compound 5-methyl-2-[(2E 6E)-3 7 11-trimethyl-2 6 10-dodecatrienyl]-1 3-benzenediol extracted from rhododendron nyingchiense in preparation of protein tyrosine phosphatase 1B inhibitor. CN110575449. 2019."},{"key":"e_1_3_5_61_1","unstructured":"Wang W Hu B. Preparation method of diabetic drug benzoxazole ethoxycyclobutylamine derivative. CN110776504. 2020."},{"key":"e_1_3_5_62_1","unstructured":"Hu B Wang W. Preparation of halogenated benzoisoxazole derivative as PTP1B inhibitor. CN110804025. 2020."},{"key":"e_1_3_5_63_1","unstructured":"Nie Y Wang W. Preparation method of chlorophenyl isoxazole-aminobenzoic acid derivative applied to preparation of protein-tyrosine phosphatase 1B (PTP1B) inhibitor and drug for treating diabetes. CN110922368. 2020."},{"key":"e_1_3_5_64_1","unstructured":"Kong F Zhao Y Ma Q et al. Mixed terpene compound verruculide B4 its preparation method and application for treating type 2 diabetes. CN111153883. 2020."},{"key":"e_1_3_5_65_1","unstructured":"Hong B He J Fan C et al. Butenolide derivative with protein-tyrosine-phosphatase 1B (PTP1B) inhibitory activity its preparation method and application in preparing drugs for treating diabetes. CN111393421. 2020."},{"key":"e_1_3_5_66_1","unstructured":"Mao S Qu K Li J et al. New compound with effect of lowering blood glucose and its preparation method and application in preparing drug or food for treating diabetes obesity and their complications. CN113461532. 2021."},{"key":"e_1_3_5_67_1","unstructured":"Yang J Ye F Tian J et al. Preparation method of dianthrone compound and its application in preventing and treating insulin-resistant related metabolic disease such as diabetes and hyperlipemia. CN114377023. 2022."},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026620999200904121432"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00965-1"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.005553"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801599"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2009.444"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01162.x"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/680348"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15195"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00678"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2016-0064"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.2.223"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.06.009"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2621091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:49:02Z","timestamp":1772718542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2621091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/13543776.2026.2621091"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2621091","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}